Gil T, Jin B, Park Y, Kim H, An H
Acta Derm Venereol. 2023; 103:adv11593.
PMID: 37955529
PMC: 10655128.
DOI: 10.2340/actadv.v103.11593.
Almutairi N, Almutawa F
Postepy Dermatol Alergol. 2017; 34(3):207-215.
PMID: 28670248
PMC: 5471376.
DOI: 10.5114/ada.2017.67843.
Well S, Diel F
Mediators Inflamm. 1993; 2(6):411-5.
PMID: 18475556
PMC: 2365435.
DOI: 10.1155/S0962935193000584.
Schopf R, Weber H, MORSCHES B
Arch Dermatol Res. 1993; 285(5):305-9.
PMID: 8379692
DOI: 10.1007/BF00371602.
Leung D, Harbeck R, Bina P, Reiser R, Yang E, Norris D
J Clin Invest. 1993; 92(3):1374-80.
PMID: 7690780
PMC: 288279.
DOI: 10.1172/JCI116711.
Production of interferon and lymphoproliferative response in whole blood cultures derived from patients with atopic dermatitis.
Kapp A, Gillitzer R, Kirchner H, Schopf E
Arch Dermatol Res. 1987; 279 Suppl:S55-8.
PMID: 3116950
DOI: 10.1007/BF00585921.
Dermatology.
Rustin M
Postgrad Med J. 1990; 66(781):894-905.
PMID: 2148371
PMC: 2429766.
DOI: 10.1136/pgmj.66.781.894.
Evidence that defective interferon-gamma production in atopic dermatitis patients is due to intrinsic abnormalities.
Reinhold U, Wehrmann W, Kukel S, Kreysel H
Clin Exp Immunol. 1990; 79(3):374-9.
PMID: 2107991
PMC: 1534961.
DOI: 10.1111/j.1365-2249.1990.tb08098.x.
T cell receptor gamma delta bearing cells are decreased in the peripheral blood of patients with atopic diseases.
Schauer U, Dippel E, Gieler U, Brauer J, Jung T, Heymanns J
Clin Exp Immunol. 1991; 86(3):440-3.
PMID: 1836160
PMC: 1554193.
DOI: 10.1111/j.1365-2249.1991.tb02950.x.
Functional characterization of skin-infiltrating lymphocytes in atopic dermatitis.
Reinhold U, Kukel S, Goeden B, Neumann U, Kreysel H
Clin Exp Immunol. 1991; 86(3):444-8.
PMID: 1721013
PMC: 1554198.
DOI: 10.1111/j.1365-2249.1991.tb02951.x.
Characterization of grass pollen reactive T-cell lines derived from lesional atopic skin.
Feldmann A, Rotte M, Neumann C
Arch Dermatol Res. 1991; 283(2):71-6.
PMID: 1712577
DOI: 10.1007/BF00371611.
Imbalance of CD4+CD45R+ and CD4+CD29+ T helper cell subsets in patients with atopic diseases.
Schauer U, Jung T, Heymanns J, Rieger C
Clin Exp Immunol. 1991; 83(1):25-9.
PMID: 1703056
PMC: 1535447.
DOI: 10.1111/j.1365-2249.1991.tb05582.x.
Interleukin 2 therapy in severe atopic dermatitis.
Hsieh K, Chou C, Huang S
J Clin Immunol. 1991; 11(1):22-8.
PMID: 1673687
DOI: 10.1007/BF00918791.
Increased plasma tumour necrosis factor-alpha concentration in atopic dermatitis.
Sumimoto S, Kawai M, KASAJIMA Y, Hamamoto T
Arch Dis Child. 1992; 67(3):277-9.
PMID: 1575548
PMC: 1793658.
DOI: 10.1136/adc.67.3.277.
Immunopathology of atopic dermatitis.
Leung D
Springer Semin Immunopathol. 1992; 13(3-4):427-40.
PMID: 1411907
DOI: 10.1007/BF00200539.
Thymopentin treatment in severe atopic dermatitis--clinical and immunological evaluations.
Hsieh K, Shaio M, Liao T
Arch Dis Child. 1992; 67(9):1095-102.
PMID: 1329673
PMC: 1793621.
DOI: 10.1136/adc.67.9.1095.